DHR vs MRVL: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Marvell Technology, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Marvell Technology, Inc. · Technology
$133.37
+25.2% upside to fair value
High Conviction
Grade B
QuantHub Verdict
MRVL has more upside to fair value
(+25.2%).
DHR trades at a lower forward P/E
(33.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MRVL |
| Current Price |
$174.04 |
$133.37 |
| Fair Value Estimate |
$197.01 |
$167.00 |
| Upside to Fair Value |
+13.2%
|
+25.2%
|
| Market Cap |
$123.2B |
$116.6B |
| Forward P/E |
33.4x
|
42.4x
|
| EV / EBITDA |
20.3x
|
—
|
| Price / Sales |
5.0x
|
14.2x
|
| Price / FCF |
23.3x
|
83.7x
|
| Revenue Growth YoY |
+3.7%
|
+7.0%
|
| Gross Margin |
60.7%
|
50.1%
|
| Operating Margin |
21.0%
|
16.3%
|
| Return on Equity |
7.1%
|
19.4%
|
| Dividend Yield |
0% |
— |
| FCF Yield |
4.3%
|
1.2%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Marvell Technology designs semiconductors for data infrastructure, including storage, networking, connectivity for AI, cloud, 5G, and automotive; the business excels with a dominant Data Center segment driving 42% FY2026 revenue growth to $8.2B amid AI demand, strong leadership under long-tenured CEO Matt Murphy, and robust 50% gross margins, though offset by earnings decline and non-Data Center …
Accumulation Zones
| Metric |
DHR |
MRVL |
| Zone Low |
$147.76 |
$125.00 |
| Zone High |
$167.46 |
$142.00 |
| In Buy Zone? |
No
|
Yes
|